American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
10 2021
Historique:
received: 10 02 2021
accepted: 10 03 2021
pubmed: 5 8 2021
medline: 13 10 2021
entrez: 4 8 2021
Statut: ppublish

Résumé

To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID-19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious disease specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings. Despite a paucity of direct evidence, 74 draft guidance statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination. These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.

Identifiants

pubmed: 34346564
doi: 10.1002/art.41928
pmc: PMC8426685
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Practice Guideline Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e60-e75

Subventions

Organisme : CSRD VA
ID : I01 CX001791
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021, American College of Rheumatology.

Références

Lancet Rheumatol. 2021 Jan;3(1):e6-e8
pubmed: 33521668
Nature. 2020 Oct;586(7830):594-599
pubmed: 32998157
J Rheumatol. 2012 Jan;39(1):167-73
pubmed: 22089462
Rheumatology (Oxford). 2012 Apr;51(4):695-700
pubmed: 22171015
Arthritis Care Res (Hoboken). 2013 Mar;65(3):476-80
pubmed: 22949223
Ann Rheum Dis. 2020 Jul;79(7):859-866
pubmed: 32471903
RMD Open. 2019 Sep 9;5(2):e001035
pubmed: 31565247
Ann Rheum Dis. 2019 Sep;78(9):1283-1284
pubmed: 30904830
Arthritis Rheumatol. 2021 Jun;73(6):914-920
pubmed: 33305544
Ann Rheum Dis. 2020 Jan;79(1):39-52
pubmed: 31413005
Antivir Ther. 2012;17(5):893-903
pubmed: 22544169
RMD Open. 2019 Sep 3;5(2):e001018
pubmed: 31565246
Ann Rheum Dis. 2013 Nov;72(11):1800-5
pubmed: 23178206
Arthritis Rheumatol. 2021 Feb;73(2):e1-e12
pubmed: 33277981
Arthritis Care Res (Hoboken). 2012 May;64(5):625-39
pubmed: 22473917
ACR Open Rheumatol. 2021 Feb;3(2):111-115
pubmed: 33527691
Ann Rheum Dis. 2013 May;72(5):659-64
pubmed: 22589375
Arthritis Care Res (Hoboken). 2014 Jul;66(7):1016-26
pubmed: 24339395
ACR Open Rheumatol. 2021 May;3(5):333-340
pubmed: 33856739
Lupus. 2017 Sep;26(10):1072-1081
pubmed: 28420056
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Arthritis Rheum. 2011 Jun;63(6):1486-96
pubmed: 21384334
Arthritis Res Ther. 2014 Jan 02;16(1):R2
pubmed: 24383620
BMC Musculoskelet Disord. 2012 Aug 27;13:158
pubmed: 22925480
Hum Vaccin Immunother. 2016 Sep;12(9):2391-402
pubmed: 27246296
J Rheumatol. 2018 Jun;45(6):733-744
pubmed: 29545454
Ann Rheum Dis. 2016 Apr;75(4):687-95
pubmed: 25795907
Mod Rheumatol. 2014 May;24(3):511-6
pubmed: 24252023
Eur J Cancer. 2020 Sep;136:4-6
pubmed: 32619884
Clin Exp Immunol. 2020 Nov;202(2):149-161
pubmed: 32671831
Arthritis Rheum. 2010 Jan;62(1):75-81
pubmed: 20039396
Rheumatology (Oxford). 2021 Oct 9;60(SI):SI59-SI67
pubmed: 33369663
medRxiv. 2020 Dec 07;:
pubmed: 33330890
Clin Rheumatol. 2020 Feb;39(2):375-379
pubmed: 31823141
J Infect Dis. 2015 Jul 1;212(1):137-46
pubmed: 25589334
Vaccine. 2020 Jan 22;38(4):847-851
pubmed: 31767465
BMC Infect Dis. 2009 Dec 15;9:207
pubmed: 20003535
Arthritis Rheumatol. 2016 Sep;68(9):2328-37
pubmed: 26990731
Nephrol Dial Transplant. 1998 Jan;13(1):160-4
pubmed: 9481733
Vaccines (Basel). 2020 Aug 14;8(3):
pubmed: 32824111
Arthritis Res Ther. 2015 Dec 10;17:357
pubmed: 26653668
Arthritis Rheumatol. 2018 Jun;70(6):826-831
pubmed: 29532625
Am J Transplant. 2013 Apr;13(4):1026-1033
pubmed: 23406320
Ann Rheum Dis. 2017 Sep;76(9):1559-1565
pubmed: 28468794
Ann Rheum Dis. 2018 Jun;77(6):898-904
pubmed: 29572291
Ann Rheum Dis. 2015 May;74(5):818-22
pubmed: 24448345
Blood. 2013 Sep 12;122(11):1946-53
pubmed: 23851398
Nature. 2020 Aug;584(7821):430-436
pubmed: 32640463
Vaccine. 2011 Feb 11;29(8):1643-8
pubmed: 21211590
Autoimmun Rev. 2011 Apr;10(6):341-52
pubmed: 21182987
Arthritis Res Ther. 2010;12(3):R111
pubmed: 20529331
Clin Exp Immunol. 2014 Oct;178(1):40-7
pubmed: 24889761
Clin Infect Dis. 2014 Feb;58(3):e44-100
pubmed: 24311479
Arthritis Rheumatol. 2016 Jan;68(1):1-26
pubmed: 26545940
Arthritis Rheumatol. 2019 Jan;71(1):5-32
pubmed: 30499246
Ann Rheum Dis. 2012 Dec;71(12):2006-10
pubmed: 22887851
Arthritis Rheumatol. 2021 Jul;73(7):1108-1123
pubmed: 34101376
J Infect Dis. 2013 Jan 15;207(2):240-7
pubmed: 23125444
RMD Open. 2019 Sep 19;5(2):e001041
pubmed: 31673420
Arthritis Rheum. 1998 Oct;41(10):1828-34
pubmed: 9778224
Arthritis Res Ther. 2015 Jun 03;17:149
pubmed: 26036592
Arthritis Care Res (Hoboken). 2011 Jul;63(7):1062-7
pubmed: 21425247
Am J Nephrol. 2008;28(4):654-60
pubmed: 18322360
Arthritis Rheum. 2010 Jan;62(1):64-74
pubmed: 20039397
JAMA Intern Med. 2020 Jul 1;180(7):934-943
pubmed: 32167524
Clin Infect Dis. 2014 Feb;58(3):309-18
pubmed: 24421306
Ann Rheum Dis. 2021 Aug;80(8):1098-1099
pubmed: 33757968
Ann Rheum Dis. 2013 Aug;72(8):1362-6
pubmed: 23345600
Neurology. 2020 Oct 6;95(14):e1999-e2008
pubmed: 32727835
BMC Musculoskelet Disord. 2016 May 26;17:231
pubmed: 27229685
Arthritis Rheumatol. 2021 Mar;73(3):374-380
pubmed: 33146001
Arthritis Res Ther. 2019 Apr 18;21(1):102
pubmed: 30999933
JAMA. 2021 May 4;325(17):1784-1786
pubmed: 33720292
J Rheumatol. 2017 Jul;44(7):1083-1087
pubmed: 28298565
Vaccine. 2017 Feb 7;35(6):903-908
pubmed: 28081972
N Engl J Med. 2020 Dec 3;383(23):2291-2293
pubmed: 33176080
Ann Rheum Dis. 2020 Aug 11;:
pubmed: 32788398
J Clin Epidemiol. 2011 Dec;64(12):1303-10
pubmed: 21802903
Ann Rheum Dis. 2021 Jul;80(7):930-942
pubmed: 33504483
Arthritis Rheum. 2011 Dec;63(12):3723-32
pubmed: 21834061
Ann Rheum Dis. 2011 Mar;70(3):414-22
pubmed: 21131643

Auteurs

Jeffrey R Curtis (JR)

University of Alabama at Birmingham.

Sindhu R Johnson (SR)

Toronto Western Hospital, Mount Sinai Hospital, and University of Toronto, Toronto, Ontario, Canada.

Donald D Anthony (DD)

Louis Stokes Cleveland VA Medical Center, MetroHealth Medical Center, and Case Western Reserve University, Cleveland, Ohio, United States.

Reuben J Arasaratnam (RJ)

VA North Texas Health Care System and University of Texas Southwestern Medical Center, Dallas.

Lindsey R Baden (LR)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Anne R Bass (AR)

Hospital for Special Surgery and Weill Cornell Medicine, New York, New York, United States.

Cassandra Calabrese (C)

Cleveland Clinic, Cleveland, Ohio, United States.

Ellen M Gravallese (EM)

Brigham and Women's Hospital, Boston, Massachusetts, United States.

Rafael Harpaz (R)

Harpaz Herman Consultants, Atlanta, Georgia, United States.

Andrew Kroger (A)

CDC, Atlanta, Georgia, United States.

Rebecca E Sadun (RE)

Duke University, Durham, North Carolina, United States.

Amy S Turner (AS)

American College of Rheumatology, Atlanta, Georgia, United States.

Eleanor Anderson Williams (EA)

The Permanente Medical Group, Union City, California, United States.

Ted R Mikuls (TR)

University of Nebraska Medical Center and VA Nebraska-Western Iowa Health Care System, Omaha.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH